| KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer W Liao, MJ Overman, AT Boutin, X Shang, DI Zhao, P Dey, J Li, G Wang, ... Cancer cell 35 (4), 559-572. e7, 2019 | 524 | 2019 |
| TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs X Su, D Chakravarti, MS Cho, L Liu, YJ Gi, YL Lin, ML Leung, A El-Naggar, ... Nature 467 (7318), 986-990, 2010 | 508 | 2010 |
| Telomeres: history, health, and hallmarks of aging D Chakravarti, KA LaBella, RA DePinho Cell 184 (2), 306-322, 2021 | 453 | 2021 |
| Genetic and biological hallmarks of colorectal cancer J Li, X Ma, D Chakravarti, S Shalapour, RA DePinho Genes & development 35 (11-12), 787-820, 2021 | 397 | 2021 |
| Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer D Zhao, X Lu, G Wang, Z Lan, W Liao, J Li, X Liang, JR Chen, S Shah, ... Nature 542 (7642), 484-488, 2017 | 211 | 2017 |
| ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression YH Ahn, DL Gibbons, D Chakravarti, CJ Creighton, ZH Rizvi, HP Adams, ... The Journal of clinical investigation 122 (9), 3170-3183, 2012 | 196 | 2012 |
| p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis X Su, D Chakravarti, ER Flores Nature reviews Cancer 13 (2), 136-143, 2013 | 177 | 2013 |
| Oncogenic KRAS-driven metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment P Dey, J Li, J Zhang, S Chaurasiya, A Strom, H Wang, WT Liao, ... Cancer discovery 10 (4), 608-625, 2020 | 165 | 2020 |
| IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo A Venkatanarayan, P Raulji, W Norton, D Chakravarti, C Coarfa, X Su, ... Nature 517 (7536), 626-630, 2015 | 135 | 2015 |
| TAp63 is a master transcriptional regulator of lipid and glucose metabolism X Su, YJ Gi, D Chakravarti, IL Chan, A Zhang, X Xia, KY Tsai, ER Flores Cell metabolism 16 (4), 511-525, 2012 | 131 | 2012 |
| BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling H Vin, SS Ojeda, G Ching, ML Leung, V Chitsazzadeh, DW Dwyer, ... Elife 2, e00969, 2013 | 92 | 2013 |
| Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8 D Chakravarti, X Su, MS Cho, NHB Bui, C Coarfa, A Venkatanarayan, ... Proceedings of the National Academy of Sciences 111 (5), E572-E581, 2014 | 85 | 2014 |
| Histone demethylase KDM5D upregulation drives sex differences in colon cancer J Li, Z Lan, W Liao, JW Horner, X Xu, J Liu, Y Yoshihama, S Jiang, ... Nature 619 (7970), 632-639, 2023 | 72 | 2023 |
| Telomere dysfunction activates YAP1 to drive tissue inflammation D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ... Nature communications 11 (1), 4766, 2020 | 71 | 2020 |
| SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63 C Bornstein, R Brosh, A Molchadsky, S Madar, I Kogan-Sakin, I Goldstein, ... Molecular and cellular biology, 2011 | 56 | 2011 |
| Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor S Adhikary, D Chakravarti, C Terranova, I Sengupta, M Maitituoheti, ... Nature communications 10 (1), 1398, 2019 | 53 | 2019 |
| Telomere dysfunction instigates inflammation in inflammatory bowel disease D Chakravarti, R Lee, AS Multani, A Santoni, Z Keith, WH Hsu, K Chang, ... Proceedings of the National Academy of Sciences 118 (29), e2024853118, 2021 | 41 | 2021 |
| Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer R Lee, J Li, J Li, CJ Wu, S Jiang, WH Hsu, D Chakravarti, P Chen, ... Cancer discovery 12 (7), 1702-1717, 2022 | 40 | 2022 |
| Drivers of transcriptional variance in human intestinal epithelial organoids ZK Criss 2nd, N Bhasin, SC Di Rienzi, A Rajan, K Deans-Fielder, ... Physiological Genomics 53 (11), 486-508, 2021 | 29 | 2021 |
| Selective JAK1 inhibitors for the treatment of inflammatory bowel disease OH Nielsen, TL Boye, J Gubatan, D Chakravarti, JB Jaquith, EC LaCasse Pharmacology & Therapeutics 245, 108402, 2023 | 21 | 2023 |